Waldemar Priebe
No más puestos en curso
Perfil
Waldemar Priebe is the founder of Reata Pharmaceuticals, Inc. (founded in 2002), Moleculin Biotech, Inc. (founded in 2015), and CNS Pharmaceuticals, Inc. (founded in 2017).
Antiguos cargos conocidos de Waldemar Priebe.
| Empresas | Cargo | Fin |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Fundador | - |
| CNS PHARMACEUTICALS, INC. | Fundador | - |
| REATA PHARMACEUTICALS, INC. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Waldemar Priebe
